Home -  NFO Offers

HDFC Pharma and Healthcare Fund - Growth

Category  :  Equity Funds - NFO
Open Date  :  14 Sep 2023
Close Date  :  28 Sep 2023
Type  :  Open Ended
Entry Load  :  0%
Exit Load  :  1%
Benchmark Name  :  S&P BSE Healthcare Index
Offer Documents  :  Download

Investment Details
Minimum Investment  :  100
Subsequent Investment  :  100
Multiples  :  1
Who is Eligible?
Individuals
Minor through Parent/Lawful Guardian
Foreign Institutional Investors
Financial Institutions and Investment Institutions
Non-resident Indians/Persons of Indian origin     residing abroad
Association of Persons
Partner(s) of Partnership Firms
Societies
Karta of Hindu Undivided Family
Companies
Trusts
 
Investment Objective

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.



Asset Allocaton %
Debt Instruments : 0-20%
Money Market Instruments : 0-20%
Corporate Debit/Public Sector Bonds : 0%
G Sec/T.Bills/CBLO : 0%
CP : 0%
CDs : 0%
NCDs : 0%
Floating Rate Notes : 0%
Gold : 0%
Equity related instruments : 80-100%
Derivaties : 0%









Fund Management Registrar & Transfer Agent
Sponsor Name : HDFC Asset Management Company Limited
Fund Manager : Mr. Nikhil Mathur
Since : 05 Oct 2023
Status : A
Setup Date : 05 Oct 2023
Phone : 66316300//
Address : Ramon House, 3rd Floor, H.T. Parekh Marg,169, Backbay Reclamation, Churchgate,Mumbai,Maharashtra - 400020
Email :
Computer Age Management Services Pvt. Ltd.
Address : 7th Floor, Tower II, Rayala Towers, 158,Nungambakkam,,CHENNAI - 440001
Phone : 18003010676//
Fax : N/A
Email : helpdist@camsonline.com

Disclaimer :-

1. Investors should consult their Financial Advisers if before making any Investment Decision on sutability of the Product.
2. Past performance may or may not be sustained in future and should not be used as a basis for investments.
3. Fund Returns and Benchmark Performance figures are calculated on a daily NAV to basis for the Growth option of the selected scheme for the relevant
4. The Net Assets are as per the last published Monthly AUM by the respective fund house.
5. Investors are advised to check the information Shown abobe from AMFI , Mutual Fund and Over websites before Making any Investment RR will not take any responsibility for any information provide on this website.
 
Note :- Please read the offer document carefully before investing because Mutual funds are subject to market risk.
About Us

  • About Us

  • Head Office - New Delhi 412-422, 21- Indraprakash Building, Barakhamba Road, New Delhi – 01
    Toll Free: 9350316010

Follow Us


  • SEBI Registration No: NSE Cash: INB231219636 | SEBI Registration No: NSE Derivative: INF231219636 | SEBI Registration No: BSE Cash: INB011219632 | SEBI Registration No: MCX-SX: INE261219636 | SEBI Registration No: NSE Currency: INE231219636 | SEBI Registration No: USE: INE271219631 | SEBI Registration No: CDSL: IN-DP-CDSL-3242005 | NCDEX Membership No: 00635 | MCX Membership No: 28850 | NSEL Membership No: 10650 | RBI Registration No: NBFC: N-14.03215 | IRDA Registration Number : CB-066/03 | AMFI Registration No : ARN -0032| SEBI Registration No: Merchant Banker: INM000007508

  • * Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.